+
Site Tour

Trending Controversies | AV Valves

Scientific session covering critical debates shaping the future of AV Valves interventions. Faculty and audience delve into three pivotal questions: How much should we optimize medical therapy before indicating TEER? Should we delay reparability to enhance patient outcomes? And, in the realm of TTVI, should we prioritize repair or replacement? Thought-provoking exchange of ideas and insights.

FIND OUT MORE ON AV VALVES SUMMIT 2024:

Watch on Demand videos

Related Videos

Screening Transmission | Mitral focus

Navigating the Anatomy | Mitral focus

TriClip - AVVS 1 year 1 minute Tricuspid - Video

MitraClip - AVVS 1 year 1 minute Mitral - Video

TCT 21: EXPAND G4

Tendyne™: 6-Year Outcomes

LAAO Summit - Clinical impact of PDLs

AV VALVES 2023:HF and VHD – Patient Management

Amplatzer™ Septal Occluder (ASO) technical brochure

EuroPCR 2022: Tendyne™

AV VALVES 2023: The Genesis of TEER

TRENDING TOPICS

Epic Mitral – 10-Year Clinical Outcomes

Ten-Year Follow-Up of Mitral Valve Replacement With the Epic Porcine Valve

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platfrom

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline